SCHEMBL13337352

SCHEMBL13337352

CCOC(=O)C(Oc1cccc2c1CCN2)C(=O)OCC

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 1/20 0.36
S1PR3 Q99500 1/20 0.36
ALDH1A1 P00352 3/20 0.35
GAA P10253 1/20 0.35
MAPT P10636 1/20 0.35
TSHR P16473 1/20 0.35
LMNA P02545 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
MTNR1A P48039 2/20 0.35
PLK4 O00444 1/20 0.35
DAPK3 O43293 1/20 0.35
DYRK3 O43781 1/20 0.35
JAK2 O60674 1/20 0.35
PRKD3 O94806 1/20 0.35
MAP4K4 O95819 1/20 0.35
PIM1 P11309 1/20 0.35
RPS6KB1 P23443 1/20 0.35
CDK2 P24941 1/20 0.35
MAPK1 P28482 1/20 0.35
KDR P35968 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15451286 0.82 PPARA (0.41) ALDH1A1TSHRMTNR1A
SCHEMBL15451247 0.82 PPARA (0.41) ALDH1A1TSHRMTNR1A
SCHEMBL16179792 0.79 USP2 (0.46) S1PR1ALDH1A1MAPTTSHRLMNA
SCHEMBL3376187 0.78 ADRA2A (0.35) S1PR1S1PR3MTNR1ABRD4PDGFRB
SCHEMBL15451257 0.77 KMT2A (0.49) GAATSHRCYP2C9CYP2C19TDP1
SCHEMBL1030999 0.75 S1PR1 (0.50) S1PR1S1PR3ALDH1A1SLC6A2SLC6A4
SCHEMBL20373858 0.75 NISCH (0.42) S1PR1S1PR3
SCHEMBL31686108 0.75 TSHR (0.53) ALDH1A1MAPTTSHRPLK4DAPK3
SCHEMBL6687227 0.73 MAPK1 (0.41) ALDH1A1GAAMAPTTSHRLMNA
SCHEMBL15311619 0.72 NOTUM (0.37) S1PR1S1PR3SLC6A2SLC6A4SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7737169-B2 Anionically substituted 7-nitroindoline derivatives and their uses MEDICAL RESEARCH COUNCIL (GB) 2010-06-15 US disclosed
US-20070203099-A1 Anionically substituted 7-nitroindoline derivatives and their uses UNITED KINGDOM RESEARCH AND INNOVATION (GB) 2007-08-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070203099-A1 Anionically substituted 7-nitroindoline derivatives and their uses SLC18A3, SLC18A1, SLC18A2 S1PR1 4702/4885S1PR3 4494/4885ALDH1A1 2026/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.